In Brief
This article was originally published in The Rose Sheet
Executive Summary
With earnings season in full swing, Shiseido reports sales down just over 1% for the first nine months of fiscal 2012, while sales at Inter Parfums advanced more than 6% for its fiscal year ended December 31. More news in brief.
You may also be interested in...
NY Elements Show Comes Down To Earth With Natural Scents
The Jan. 28-29 edition of Elements Showcase in New York saw a growing selection of natural and organic creations in fragrance and other beauty categories.
IGI Bets On Trispecific Antibody To Make Inroads Into Big Pharma Myeloma Turf
Ichnos Glenmark Innovation’s president and CEO talks to Scrip about the promising activity profile of the alliance’s early stage trispecific antibody versus Janssen’s teclistamab and also maintains that the setback for Gilead’s magrolimab hasn’t eclipsed prospects for its bispecific antibody.
UK Medtech Strategy Sets Out Schedule Of Milestones To FY 2026
Fourteen months on from the release of its inaugural medtech strategy, the UK MedTech Directorate has laid firm foundations and reports progress on initiatives aimed at improving technology adoption. A schedule of ambitious future timelines has also been published.